Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
Gross Profit
Charles River Laboratories International Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Charles River Laboratories International Inc
NYSE:CRL
|
Gross Profit
$1.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Gross Profit
$17.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
Danaher Corp
NYSE:DHR
|
Gross Profit
$25.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Gross Profit
$2.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Agilent Technologies Inc
NYSE:A
|
Gross Profit
$3.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Gross Profit
$5.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
See Also
What is Charles River Laboratories International Inc's Gross Profit?
Gross Profit
1.5B
USD
Based on the financial report for Mar 30, 2024, Charles River Laboratories International Inc's Gross Profit amounts to 1.5B USD.
What is Charles River Laboratories International Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
14%
Over the last year, the Gross Profit growth was 0%. The average annual Gross Profit growth rates for Charles River Laboratories International Inc have been 10% over the past three years , 11% over the past five years , and 14% over the past ten years .